Related Experiment Video
Updated: Feb 1, 2026
10:52
Closure of a Patent Foramen Ovale PFO: An Intervention Sequence
Published on: December 23, 2022
5.8K
Pharmacotherapy for patent ductus arteriosus closure
1Department of Pediatrics, University of Tennessee Health Science Center, Memphis, Tennessee.
Congenital Heart Disease
|December 12, 2018
Summary
Persistent patent ductus arteriosus (PDA) affects many premature infants. While surgical and drug treatments exist, acetaminophen shows promise for PDA closure with a good short-term safety profile, though long-term studies are needed.
Area of Science:
- Neonatal Medicine
- Pediatric Cardiology
- Pharmacology
Background:
- Persistent patent ductus arteriosus (PDA) affects up to 60% of premature infants born before 28 weeks gestation.
- The necessity and methods for PDA closure remain debated, despite associations with significant morbidity.
Purpose of the Study:
- To review current treatment options for PDA in premature infants.
- To evaluate the efficacy and safety of pharmacologic agents, including acetaminophen, for PDA closure.
Main Methods:
- Review of existing literature on PDA management in preterm neonates.
- Comparative analysis of surgical and pharmacologic interventions (indomethacin, ibuprofen, acetaminophen).
Main Results:
- Indomethacin and ibuprofen have established roles but carry risks like renal toxicity and hyperbilirubinemia.
- Acetaminophen demonstrates effective PDA closure with a favorable short-term safety profile.
- Long-term outcomes and optimal acetaminophen dosing/administration require further investigation.
Conclusions:
- Current PDA treatment strategies present a balance between efficacy and potential adverse effects.
- Acetaminophen is an emerging option for PDA closure, warranting continued research into its long-term safety and optimal use.
Related Concept Videos
01:26Psychosis: Goals of Pharmacotherapy
534
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
534
01:15Diabetes: Management and Pharmacotherapy
1.1K
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
1.1K
01:28Angle Closure Glaucoma: Treatment
1.3K
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
1.3K